# Cotinga Pharmaceuticals Inc.: Form D filings

Cotinga Pharmaceuticals Inc., a biotechnology company in London, Ontario, Canada, filed 13 Form D notices with the SEC between 2013 and 2018. The latest, on May 15, 2018, reports $1.6 million sold of a $1.6 million offering to 6 investors.

Find out what Cotinga Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Cotinga%20Pharmaceuticals%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Cotinga%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcotinga-pharmaceuticals-inc-1585808)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Cotinga%20Pharmaceuticals%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Cotinga%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcotinga-pharmaceuticals-inc-1585808)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: SUITE 230B, THE MOGENSON CENTRE, 100 COLLIP CIRCLE, London, Ontario, Canada, N6G 4
- Phone: (519) 858-5157
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Ontario, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1585808

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 15, 2018 | New notice | $1,580,439 | $1,580,439 | $0 | 6 | May 3, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000158580818000002/0001585808-18-000002-index.htm) |
| May 24, 2017 | Amendment | $570,000 | $0 | $570,000 | 2 | Apr 11, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374017000087/0001183740-17-000087-index.htm) |
| Jun 10, 2016 | Amendment | $570,000 | $0 | $570,000 | 2 | Apr 11, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374016000371/0001183740-16-000371-index.htm) |
| May 27, 2016 | New notice | $17,415 | $0 | $17,415 | 1 | Apr 26, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374016000356/0001183740-16-000356-index.htm) |
| May 27, 2016 | New notice | $1,800,527 | $1,100,000 | $700,527 | 1 | Mar 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374016000355/0001183740-16-000355-index.htm) |
| May 27, 2016 | New notice | $29,085 | $0 | $29,085 | 3 | Mar 20, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374016000354/0001183740-16-000354-index.htm) |
| Aug 18, 2015 | New notice | $23,453 | $13,796 | $9,657 | 1 | Jul 31, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374015000218/0001183740-15-000218-index.htm) |
| May 8, 2015 | Amendment | $570,000 | $0 | $570,000 | 2 | Apr 11, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374015000094/0001183740-15-000094-index.htm) |
| Sep 25, 2014 | Amendment | $6,101 | $0 | $6,101 | 1 | Aug 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374014000306/0001183740-14-000306-index.htm) |
| Sep 25, 2014 | Amendment | $144,900 | $45,758 | $99,142 | 1 | Aug 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374014000305/0001183740-14-000305-index.htm) |
| May 6, 2014 | New notice | $570,000 | $285,000 | $285,000 | 2 | Apr 11, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374014000150/0001183740-14-000150-index.htm) |
| Sep 9, 2013 | New notice | $6,101 | $0 | $6,101 | 1 | Aug 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374013000344/0001183740-13-000344-index.htm) |
| Sep 4, 2013 | New notice | $144,900 | $45,758 | $99,142 | 1 | Aug 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1585808/000118374013000337/0001183740-13-000337-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| DAVID S SANDERSON | Director |  |
| JOHN S YOO | Director |  |
| GENE KELLY | Executive Officer |  |
| JOHN C DRAKE | Director |  |
| ALISON SILVA | Executive Officer, Director |  |
| DOUGLAS S ALEXANDER | Director |  |

[Every Form D from the week of May 14, 2018](https://specstream.ai/data/form-d/week/2018-05-14) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Cotinga Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).